Multi-Institutional Validation of a Mammography-Based Breast Cancer Risk Model Metastatic breast cancer (mBrCa) is most often an incurable disease with only modest responses to available ...
Forty-two patients with mBrCa refractory to previous lines of treatment underwent surgical resection of a metastatic lesion(s), isolation of TIL cultures, identification of exomic nonsynonymous tumor ...
In a recent study published in Scientific Reports, researchers examined the relationship between cell-mediated or T lymphocyte-mediated immunity and severe acute respiratory syndrome coronavirus 2 ...
Adoptive cell therapy (ACT) has become a promising immunotherapy tool to help treat advanced melanoma. The therapy, which harnesses immune cells collected from the patient's own tumors, could provide ...
Scientists at the National Cancer Institute (NCI) report that in a clinical trial of 42 women with metastatic breast cancer, 28 (or 67 percent) generated an immune reaction against their cancer. The ...
Adoptive cell therapy (ACT) has become a promising immunotherapy tool to help treat advanced melanoma. The therapy, which harnesses immune cells collected from the patient’s own tumors, could provide ...
Please provide your email address to receive an email when new articles are posted on . At baseline, patients with JIA had higher C-reactive protein and CRP-to-albumin ratio vs. controls. C-reactive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results